Estimating cancer risks from a retrospective cohort of patients with MMR gene mutations.
暂无分享,去创建一个
[1] Markus Loeffler,et al. Risks of less common cancers in proven mutation carriers with lynch syndrome. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] H. Perdry,et al. Estimating penetrance from multiple case families with predisposing mutations: extension of the ‘genotype-restricted likelihood’ (GRL) method , 2011, European Journal of Human Genetics.
[3] M. Kloor,et al. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[4] J. Chang-Claude,et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes , 2005, Genetic epidemiology.
[5] H C van Houwelingen,et al. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment , 2005, Journal of Medical Genetics.
[6] C. Bonaïti‐pellié,et al. Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset , 2004, Genetic epidemiology.
[7] J. Stockman. Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome , 2013 .